Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach

Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple sclerosis (RRMS) and sometimes overlooked. This multicenter, non-interventional study evaluated whether patient-reported outcomes measures (PROMs)...

Full description

Saved in:
Bibliographic Details
Published inMultiple sclerosis journal - experimental, translational and clinical Vol. 9; no. 2; p. 20552173231169475
Main Authors Sainz de la Maza, Susana, Gómez-Ballesteros, Rocío, Borges, Mónica, Martín-Martínez, Jesús, Sotoca, Javier, Alonso, Ana, Caminero, Ana B, Borrega, Laura, Sánchez-Menoyo, José L, Barrero-Hernández, Francisco J, Calles, Carmen, Brieva, Luis, Blasco-Quílez, María R, Dotor García-Soto, Julio, Campo-Amigo, María del, Navarro-Cantó, Laura, Agüera, Eduardo, Garcés-Redondo, Moisés, Carmona, Olga, Gabaldón-Torres, Laura, Forero, Lucía, Hervàs, Mariona, Medrano, Nicolás, Maurino, Jorge, Castillo-Triviño, Tamara
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.04.2023
Sage Publications Ltd
Subjects
Online AccessGet full text
ISSN2055-2173
2055-2173
DOI10.1177/20552173231169475

Cover

Abstract Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple sclerosis (RRMS) and sometimes overlooked. This multicenter, non-interventional study evaluated whether patient-reported outcomes measures (PROMs) could capture disability in 189 early-stage RRMS patients (mean age: 36.1 ± 9.4 years, 71.4% female, mean disease duration: 1.4 ± 0.8 years, median EDSS: 1.0). The 9-Hole Peg Test (9-HPT), NeuroQoL Upper Extremity (NeuroQoL-UE), Timed 25-Foot Walk (T25-FW), Multiple Sclerosis Walking Scale (MSWS-12), Symbol Digit Modalities Test (SDMT), and Perceived Deficits Questionnaire (PDQ-5) were used to assess hand function, gait, and cognition, respectively. These functions were at least mildly affected in this early-stage population, finding significant correlations between PROMs and clinical assessments. PROMs could enable early-stage RRMS patients to communicate their perceived disability in different domains, assisting clinicians in disease monitoring and decision making.
AbstractList Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple sclerosis (RRMS) and sometimes overlooked. This multicenter, non-interventional study evaluated whether patient-reported outcomes measures (PROMs) could capture disability in 189 early-stage RRMS patients (mean age: 36.1 ± 9.4 years, 71.4% female, mean disease duration: 1.4 ± 0.8 years, median EDSS: 1.0). The 9-Hole Peg Test (9-HPT), NeuroQoL Upper Extremity (NeuroQoL-UE), Timed 25-Foot Walk (T25-FW), Multiple Sclerosis Walking Scale (MSWS-12), Symbol Digit Modalities Test (SDMT), and Perceived Deficits Questionnaire (PDQ-5) were used to assess hand function, gait, and cognition, respectively. These functions were at least mildly affected in this early-stage population, finding significant correlations between PROMs and clinical assessments. PROMs could enable early-stage RRMS patients to communicate their perceived disability in different domains, assisting clinicians in disease monitoring and decision making.Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple sclerosis (RRMS) and sometimes overlooked. This multicenter, non-interventional study evaluated whether patient-reported outcomes measures (PROMs) could capture disability in 189 early-stage RRMS patients (mean age: 36.1 ± 9.4 years, 71.4% female, mean disease duration: 1.4 ± 0.8 years, median EDSS: 1.0). The 9-Hole Peg Test (9-HPT), NeuroQoL Upper Extremity (NeuroQoL-UE), Timed 25-Foot Walk (T25-FW), Multiple Sclerosis Walking Scale (MSWS-12), Symbol Digit Modalities Test (SDMT), and Perceived Deficits Questionnaire (PDQ-5) were used to assess hand function, gait, and cognition, respectively. These functions were at least mildly affected in this early-stage population, finding significant correlations between PROMs and clinical assessments. PROMs could enable early-stage RRMS patients to communicate their perceived disability in different domains, assisting clinicians in disease monitoring and decision making.
Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple sclerosis (RRMS) and sometimes overlooked. This multicenter, non-interventional study evaluated whether patient-reported outcomes measures (PROMs) could capture disability in 189 early-stage RRMS patients (mean age: 36.1 ± 9.4 years, 71.4% female, mean disease duration: 1.4 ± 0.8 years, median EDSS: 1.0). The 9-Hole Peg Test (9-HPT), NeuroQoL Upper Extremity (NeuroQoL-UE), Timed 25-Foot Walk (T25-FW), Multiple Sclerosis Walking Scale (MSWS-12), Symbol Digit Modalities Test (SDMT), and Perceived Deficits Questionnaire (PDQ-5) were used to assess hand function, gait, and cognition, respectively. These functions were at least mildly affected in this early-stage population, finding significant correlations between PROMs and clinical assessments. PROMs could enable early-stage RRMS patients to communicate their perceived disability in different domains, assisting clinicians in disease monitoring and decision making.
Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple sclerosis (RRMS) and sometimes overlooked. This multicenter, non-interventional study evaluated whether patient-reported outcomes measures (PROMs) could capture disability in 189 early-stage RRMS patients (mean age: 36.1 ± 9.4 years, 71.4% female, mean disease duration: 1.4 ± 0.8 years, median EDSS: 1.0). The 9-Hole Peg Test (9-HPT), NeuroQoL Upper Extremity (NeuroQoL-UE), Timed 25-Foot Walk (T25-FW), Multiple Sclerosis Walking Scale (MSWS-12), Symbol Digit Modalities Test (SDMT), and Perceived Deficits Questionnaire (PDQ-5) were used to assess hand function, gait, and cognition, respectively. These functions were at least mildly affected in this early-stage population, finding significant correlations between PROMs and clinical assessments. PROMs could enable early-stage RRMS patients to communicate their perceived disability in different domains, assisting clinicians in disease monitoring and decision making.
Author Barrero-Hernández, Francisco J
Sotoca, Javier
Borrega, Laura
Sánchez-Menoyo, José L
Carmona, Olga
Blasco-Quílez, María R
Campo-Amigo, María del
Castillo-Triviño, Tamara
Forero, Lucía
Navarro-Cantó, Laura
Medrano, Nicolás
Hervàs, Mariona
Dotor García-Soto, Julio
Gabaldón-Torres, Laura
Gómez-Ballesteros, Rocío
Agüera, Eduardo
Borges, Mónica
Garcés-Redondo, Moisés
Calles, Carmen
Martín-Martínez, Jesús
Alonso, Ana
Brieva, Luis
Sainz de la Maza, Susana
Caminero, Ana B
Maurino, Jorge
Author_xml – sequence: 1
  givenname: Susana
  surname: Sainz de la Maza
  fullname: Sainz de la Maza, Susana
  organization: , Universidad de Alcalá, Madrid, Spain
– sequence: 2
  givenname: Rocío
  orcidid: 0000-0001-9582-9230
  surname: Gómez-Ballesteros
  fullname: Gómez-Ballesteros, Rocío
  organization: Medical Department, Roche Farma, Madrid, Spain
– sequence: 3
  givenname: Mónica
  surname: Borges
  fullname: Borges, Mónica
  organization: , Sevilla, Spain
– sequence: 4
  givenname: Jesús
  surname: Martín-Martínez
  fullname: Martín-Martínez, Jesús
  organization: , Zaragoza, Spain
– sequence: 5
  givenname: Javier
  surname: Sotoca
  fullname: Sotoca, Javier
  organization: , Terrassa, Spain
– sequence: 6
  givenname: Ana
  orcidid: 0000-0002-7337-8384
  surname: Alonso
  fullname: Alonso, Ana
  organization: Department of Neurology, Hospital Regional Universitario de Málaga, Málaga, Spain
– sequence: 7
  givenname: Ana B
  surname: Caminero
  fullname: Caminero, Ana B
  organization: , Ávila, Spain
– sequence: 8
  givenname: Laura
  surname: Borrega
  fullname: Borrega, Laura
  organization: , Alcorcón, Spain
– sequence: 9
  givenname: José L
  surname: Sánchez-Menoyo
  fullname: Sánchez-Menoyo, José L
  organization: Department of Neurology, Hospital de Galdakao-Usansolo, Galdakao, Spain
– sequence: 10
  givenname: Francisco J
  surname: Barrero-Hernández
  fullname: Barrero-Hernández, Francisco J
  organization: , Granada, Spain
– sequence: 11
  givenname: Carmen
  surname: Calles
  fullname: Calles, Carmen
  organization: Department of Neurology, Hospital Universitari Son Espases, Palma de Mallorca, Spain
– sequence: 12
  givenname: Luis
  surname: Brieva
  fullname: Brieva, Luis
  organization: , Lleida, Spain
– sequence: 13
  givenname: María R
  surname: Blasco-Quílez
  fullname: Blasco-Quílez, María R
  organization: , Madrid, Spain
– sequence: 14
  givenname: Julio
  surname: Dotor García-Soto
  fullname: Dotor García-Soto, Julio
  organization: , Sevilla, Spain
– sequence: 15
  givenname: María del
  surname: Campo-Amigo
  fullname: Campo-Amigo, María del
  organization: , Pontevedra, Spain
– sequence: 16
  givenname: Laura
  surname: Navarro-Cantó
  fullname: Navarro-Cantó, Laura
  organization: , Elche, Spain
– sequence: 17
  givenname: Eduardo
  surname: Agüera
  fullname: Agüera, Eduardo
  organization: Department of Neurology, Hospital Universitario Reina Sofía, Córdoba, Spain
– sequence: 18
  givenname: Moisés
  orcidid: 0000-0002-1756-5492
  surname: Garcés-Redondo
  fullname: Garcés-Redondo, Moisés
  organization: , Zaragoza, Spain
– sequence: 19
  givenname: Olga
  surname: Carmona
  fullname: Carmona, Olga
  organization: Department of Neurology, Fundació Salut Empordà, Figueres, Spain
– sequence: 20
  givenname: Laura
  surname: Gabaldón-Torres
  fullname: Gabaldón-Torres, Laura
  organization: Department of Neurology, Hospital Francesc de Borja, Gandía, Spain
– sequence: 21
  givenname: Lucía
  orcidid: 0000-0003-0256-6748
  surname: Forero
  fullname: Forero, Lucía
  organization: Department of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain
– sequence: 22
  givenname: Mariona
  surname: Hervàs
  fullname: Hervàs, Mariona
  organization: , Sabadell, Spain
– sequence: 23
  givenname: Nicolás
  surname: Medrano
  fullname: Medrano, Nicolás
  organization: Medical Department, Roche Farma, Madrid, Spain
– sequence: 24
  givenname: Jorge
  orcidid: 0000-0001-9858-3555
  surname: Maurino
  fullname: Maurino, Jorge
  organization: Medical Department, Roche Farma, Madrid, Spain
– sequence: 25
  givenname: Tamara
  orcidid: 0000-0002-9249-3185
  surname: Castillo-Triviño
  fullname: Castillo-Triviño, Tamara
  organization: , San Sebastián, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37187856$$D View this record in MEDLINE/PubMed
BookMark eNp1Ustu1TAQtVARfdAPYIMssWGTksm1k5gNQqU8pCuxgXU0cSa3Lo4dbAfpfgz_isMtpYBY2TpzzvHxzJyyI-cdMfYEyguApnlRlVJW0GyqDUCtRCMfsJMVK1bw6N79mJ3HeFOWJcg6g_CIHW8aaJtW1ifs-xtKpJNxOz6YiL2xJu35Elcgkh2LQLMPiQaObuDaGmc0Wo4xUowTuRS5cZww2H0RE-6IB7I4r_osnUz6aT0tNpnZEo_aUvDRxJd86_2XtTb6wJFrP-X6aohhz3Geg0d9_Zg9HNFGOr89z9jnt1efLt8X24_vPly-3hZagErFUCsgOfaDRAIlGyF02fdY6lGMGySBQEK1Wo8gmkFVlQBUKITKKlq7sjljrw6-89JPNOgcI6Dt5mCmHKfzaLo_K85cdzv_rYMSmlrWZXZ4fusQ_NeFYuomEzVZi478EruqBSEr0SqZqc_-ot74Jbj8v8yqVF3nabaZ9fR-pLssv0aXCXAg6NzQGGi8o0DZrRvS_bMhWXNx0MQ8qd_P_l_wAyoQvu4
Cites_doi 10.7224/1537-2073.2015-028
10.1177/1352458517690824
10.1093/brain/awac111
10.1177/1352458515599450
10.1186/s12883-015-0296-2
10.1016/j.rehab.2021.101491
10.1016/j.msard.2022.103757
10.1093/qjmed/hcx070
10.1212/01.wnl.0000436065.97642.d2
10.1016/S1474-4422(17)30470-2
10.1001/jamaneurol.2022.4655
10.1212/WNL.60.1.31
10.1111/ene.14866
ContentType Journal Article
Copyright The Author(s), 2023
The Author(s), 2023.
The Author(s), 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s), 2023 2023 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml – notice: The Author(s), 2023
– notice: The Author(s), 2023.
– notice: The Author(s), 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s), 2023 2023 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID AFRWT
AAYXX
CITATION
NPM
7X7
7XB
8FI
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1177/20552173231169475
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
PubMed
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
PubMed

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2055-2173
ExternalDocumentID PMC10176560
37187856
10_1177_20552173231169475
10.1177_20552173231169475
Genre Journal Article
GrantInformation_xml – fundername: Roche España
  funderid: https://doi.org/10.13039/100019721
– fundername: ;
GroupedDBID 0R~
53G
54M
5VS
7X7
8FI
AAJPV
AASGM
ABAWP
ABNCE
ABQXT
ABVFX
ACARO
ACGFS
ACROE
ADBBV
ADOGD
AEUHG
AEWDL
AFCOW
AFKRA
AFKRG
AFRWT
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AUTPY
AYAKG
BCNDV
BDDNI
BENPR
BPHCQ
BSEHC
BVXVI
CCPQU
DC.
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
J8X
K.F
O9-
OK1
PHGZM
PHGZT
PIMPY
PQQKQ
ROL
RPM
SAUOL
SCDPB
SCNPE
SFC
UKHRP
AAYXX
ACHEB
CITATION
PUEGO
31X
AATBZ
ACGZU
ACSIQ
AEUIJ
AEWHI
DV7
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
NPM
SFK
SFT
SGV
SPP
7XB
ABUWG
AZQEC
DWQXO
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c419t-d691e5fbd5ae195744c0bba0cf4f3ae4a1e498ccf147d92241a9a44991ee01563
IEDL.DBID 7X7
ISSN 2055-2173
IngestDate Thu Aug 21 18:37:28 EDT 2025
Fri Sep 05 09:19:36 EDT 2025
Sun Jun 29 15:39:56 EDT 2025
Thu Jan 02 22:50:54 EST 2025
Wed Sep 10 05:15:56 EDT 2025
Tue Jun 17 22:27:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Relapsing-remitting multiple sclerosis
patient-reported outcomes
early-stage
disability progression
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
The Author(s), 2023.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c419t-d691e5fbd5ae195744c0bba0cf4f3ae4a1e498ccf147d92241a9a44991ee01563
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1756-5492
0000-0003-0256-6748
0000-0002-9249-3185
0000-0002-7337-8384
0000-0001-9858-3555
0000-0001-9582-9230
OpenAccessLink https://www.proquest.com/docview/2829666948?pq-origsite=%requestingapplication%
PMID 37187856
PQID 2829666948
PQPubID 4451081
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10176560
proquest_miscellaneous_2814524895
proquest_journals_2829666948
pubmed_primary_37187856
crossref_primary_10_1177_20552173231169475
sage_journals_10_1177_20552173231169475
PublicationCentury 2000
PublicationDate 2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-01
  day: 01
PublicationDecade 2020
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: United States
– name: Thousand Oaks
– name: Sage UK: London, England
PublicationTitle Multiple sclerosis journal - experimental, translational and clinical
PublicationTitleAlternate Mult Scler J Exp Transl Clin
PublicationYear 2023
Publisher SAGE Publications
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Sage Publications Ltd
References Zaratin, Vermersch, Amato 2022; 61
Carpinella, Gervasoni, Anastasi 2021; 28
Lopez-Gongora, Querol, Escartin 2015; 15
Feys, Lamers, Francis 2017; 23
Thompson, Banwell, Barkhof 2018; 17
Cattaneo, Gervasoni, Anastasi 2022; 65
Miller, Bethoux, Victorson 2016; 22
Portaccio, Bellinvia, Fonderico 2022; 145
Hobart, Riazi, Lamping 2003; 60
Strober, Binder, Nikelshpur 2016; 18
Tur, Carbonell-Mirabent, Cobo-Calvo 2023; 80
McNicholas, O‘Connell, Yap 2018; 111
Goldman, Motl, Scagnelli 2013; 81
bibr7-20552173231169475
bibr3-20552173231169475
bibr6-20552173231169475
bibr13-20552173231169475
bibr4-20552173231169475
bibr9-20552173231169475
bibr11-20552173231169475
bibr1-20552173231169475
bibr5-20552173231169475
bibr10-20552173231169475
bibr2-20552173231169475
bibr12-20552173231169475
bibr8-20552173231169475
References_xml – volume: 23
  start-page: 711
  year: 2017
  end-page: 720
  article-title: Multiple sclerosis outcome assessments consortium. The nine-hole peg test as a manual dexterity performance measure for multiple sclerosis
  publication-title: Mult Scler
– volume: 65
  start-page: 101491
  year: 2022
  article-title: Prevalence and patterns of subclinical motor and cognitive impairments in non-disabled individuals with early multiple sclerosis: a multicenter cross-sectional study
  publication-title: Ann Phys Rehabil Med
– volume: 60
  start-page: 31
  year: 2003
  end-page: 36
  article-title: Measuring the impact of MS on walking ability: the 12-item MS walking scale (MSWS-12)
  publication-title: Neurology
– volume: 61
  start-page: 103757
  year: 2022
  article-title: The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: progresses and open questions
  publication-title: Mult Scler Relat Disord
– volume: 80
  start-page: 151
  year: 2023
  end-page: 160
  article-title: Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis
  publication-title: JAMA Neurol
– volume: 111
  start-page: 359
  year: 2018
  end-page: 364
  article-title: Cognitive dysfunction in early multiple sclerosis: a review
  publication-title: QJM
– volume: 145
  start-page: 2796
  year: 2022
  end-page: 2805
  article-title: Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study
  publication-title: Brain
– volume: 22
  start-page: 830
  year: 2016
  end-page: 841
  article-title: Validating neuro-QoL short forms and targeted scales with people who have multiple sclerosis
  publication-title: Mult Scler
– volume: 18
  start-page: 183
  year: 2016
  end-page: 190
  article-title: The perceived deficits questionnaire: perception, deficit, or distress?
  publication-title: Int J MS Care
– volume: 28
  start-page: 2259
  year: 2021
  end-page: 2268
  article-title: Instrumentally assessed gait quality is more relevant than gait endurance and velocity to explain patient-reported walking ability in early-stage multiple sclerosis
  publication-title: Eur J Neurol
– volume: 17
  start-page: 162
  year: 2018
  end-page: 173
  article-title: Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
  publication-title: Lancet Neurol
– volume: 81
  start-page: 1856
  year: 2013
  end-page: 1863
  article-title: Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world
  publication-title: Neurology
– volume: 15
  start-page: 40
  year: 2015
  article-title: A one-year follow-up study of the symbol digit modalities test (SDMT) and the paced auditory serial addition test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity
  publication-title: BMC Neurol
– ident: bibr12-20552173231169475
  doi: 10.7224/1537-2073.2015-028
– ident: bibr7-20552173231169475
  doi: 10.1177/1352458517690824
– ident: bibr2-20552173231169475
  doi: 10.1093/brain/awac111
– ident: bibr10-20552173231169475
  doi: 10.1177/1352458515599450
– ident: bibr9-20552173231169475
  doi: 10.1186/s12883-015-0296-2
– ident: bibr3-20552173231169475
  doi: 10.1016/j.rehab.2021.101491
– ident: bibr5-20552173231169475
  doi: 10.1016/j.msard.2022.103757
– ident: bibr4-20552173231169475
  doi: 10.1093/qjmed/hcx070
– ident: bibr8-20552173231169475
  doi: 10.1212/01.wnl.0000436065.97642.d2
– ident: bibr6-20552173231169475
  doi: 10.1016/S1474-4422(17)30470-2
– ident: bibr1-20552173231169475
  doi: 10.1001/jamaneurol.2022.4655
– ident: bibr11-20552173231169475
  doi: 10.1212/WNL.60.1.31
– ident: bibr13-20552173231169475
  doi: 10.1111/ene.14866
SSID ssj0001562051
Score 2.226409
Snippet Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple...
Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple...
SourceID pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 20552173231169475
SubjectTerms Brief Report
Disability
Multiple sclerosis
Self report
SummonAdditionalLinks – databaseName: Sage Journals GOLD Open Access 2024
  dbid: AFRWT
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVKe-GCQHwtFDRISEhIhjhxEptbBawqBBxQK3qLbGdSVmKzVZM97I_hvzKTxFtWCxLX2MkkHjvz7Hl-FuJlQSEBTcG7252T2mVaurQxEvOmKSlClU3gjO6Xr8Xpuf50kV8ciFXcCzO1YPeGaVX0RsPPmkc3r0a_nZKMNGPPyUaZEThRhdUlTen7ZTUud8dTNfgK56fXS05tByZEbmTc3nZLHLF0OQ2Jo5P5t-9nN8syhAeS4dBGtiHZyJQL_avd3Wi2B1H3mZZ_0MWGCDa_K-5M0BNOxr5yTxxge1_8-oCcRqAABvUkt9tvgNnwl9Dhz0aOSQWswbU1xH2U4LaCnh0sWkCWSZYENC8ReHfMFd9Pty4XA60aIm0ROrJMX7Lo3sFnXjmmMkLN4GCgto9M9usNRKXzB-J8_vHs_amcjmyQQSvby7qwitzs69yhsnmpdUi8d0lodJM51E6htiaERumytgwfnHWaZl0Kkds-eygO21WLjwX4HL1JiuADIdTEaK-cxzRl-UafYWJm4nVs-upqVOao1CRevuenmTiOzqliF6s4iUyzN6vpWS-2xTS8OGfiWlytuY7SeaqNpUc8Gn25tZZRXC9NXsyE2fHytgJLd--WtIsfg4Q3_whZ9mgmXnGHuHmnf37Bk_-u-VTcTgmJjfSiY3HYX6_xGSGn3j-fevtvFX4Wgg
  priority: 102
  providerName: SAGE Publications
Title Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
URI https://journals.sagepub.com/doi/full/10.1177/20552173231169475
https://www.ncbi.nlm.nih.gov/pubmed/37187856
https://www.proquest.com/docview/2829666948
https://www.proquest.com/docview/2814524895
https://pubmed.ncbi.nlm.nih.gov/PMC10176560
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Na9wwEBVpcumltKQfbtJlCoVCQdRay7acS0ibLKGkoYSE7m2R5HGy0Hi38eaQH5P_mhlb3k1Y2pMx8pc8suZ55umNEJ8ycgloMl7dbq3UNtHSDisjMa2qnDxUXnnO6P48zY4v9I9xOg4BtybQKvs5sZ2oy5nnGPlXzvgR1C602Z__lVw1irOroYTGM7GlCIlw6YZ8nK9iLOTcadCFZCbrLNEuPVyeEKpRdC1mFz52R2sYc50q-Yjv1bqg0UvxImBHOOiM_UpsYL0t7g-R8wDkgaAMermLO2A6-yU0-KeSXVYAS7B1Cf1CSLBLRc4GpjUg6xxLQoqXCLy8Zc7n06nX05YXDT3vEBq6M_Vk2uzBCYd-qY1gL1houekdFf3mDnqp8tfiYnR0_v1YhpoL0mtVLGSZFYrs5MrUoirSXGsfO2djX-kqsaitQl0Y7yul87Jg_28Lq-m3SSHy-07eiM16VuM7AS5FZ-LMO08QMzbaKetwOGT9RZdgbCLxpX_1k3knrTFRQX18zU6R2O2NMwlfWTNZjYlIfFw20_fBSQ9b4-yWj1E6HWpT0CXedrZc3i0hx5ybNIuEeWLl5QGsvf20pZ5etRrcPJOxblEkPvOAWD3TP3vw_v892BHPuZJ9RwraFZuLm1v8QHhn4QbtoB6IrYPR2e9z2n47Ov11NmijBw9lVAVt
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEB7q9YN-EcW3aNUVFEEIZpNNshGKqG252ush0kK_xd1k0h5o7myuyP0Y_4q_zZlkc9dy6Ld-DJu3zczuPNl55lmAlwmFBNQJV7cb4ysTKd-ElfYxrqqUIlRaFZzRPRwnw2P1-SQ-2YA_fS0M0yr7ObGdqMtpwWvkbznjR1A7U_r97KfPu0ZxdrXfQsO4rRXK7VZizBV2HODiF_3CNdv7O2TvV2G4t3v0aei7XQb8Qsls7pdJJunNbBkblFmcKlUE1pqgqFQVGVRGosp0UVRSpWXGEc9kRtGPgkTkOuSI7nsDNhUvoAxg8-Pu-MvX1SoPwQtye5dOZaUnOqTPk0aEqyT1hvmNlwPiGspdJ2teYpy1QXDvDtx26FV86NztLmxgfQ9-7yBnIigGitIp9s4Xggn1p6LB75Xf5SWwFKYuRV-KKcxSE7QRk1ogKy37hFVPUXCBzYyvp0t_TFpmtuiZj6KhJ1NPJs07MeLFZ2oj4C2MaNnxHRn-fCF6sfT7cHwt9ngAg3pa4yMQNkarg6SwBYHcQCsrjcUwZAVIG2GgPXjTf_p81ol75NLpn6_ZyYOt3ji5G-dNvvJKD14sm2mEctrF1Di94HOkikOlM7rFw86Wy6dFBA1SHSce6CtWXp7A6t9XW-rJWasCznMpKyd58JodYvVO_-zB4__34DncHB4djvLR_vjgCdwKCc11FKUtGMzPL_Apoa-5feZcXMC36x5VfwGuG0U1
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fTxQxEG7wSIwvBgLqKWBNTExMqtvbdrfljYAXUCDGQORt0-5O8RJdLuzxwB_D_8rMbvfwcprw3N-dtjPtfPOVsfcZqgQwGUW3OyeUS5Vwo2AE6BBy1FB5KMmje3KaHZ6rrxf6Ij64USxMnMHmE8GqsEftYU27e1qFz9HHiBd2jU3kKdomMrMq10_YKl5rTDJgq3vjHz_PHl5ZUL0n7R-MVEZQoeja_Gc9i8ppyeJcBk7-hf5qFdJ4jT2PliTf60S_zlag3mB3B0BeAdRHvIrsubNbTuD2S97A7yA6HwFU3NUV78MiuZvzczZ8UnMg1mOBduMlcAp2mVJ5LPpn0qKkeY9C5A22jCOZNLv8mB6CMQ2NYO54i1TvgOnXt7wnLt9k5-MvZ_uHIv7AIEol7UxUmZUoNV9pB9LqXKky8d4lZVAhdaCcBGVNWQap8sqSNeCsU3iJkgA09-kLNqivanjFuNfgTZKVvkSDMzHKS-dhNCI2Rp9CYobsYz_1xbQj2ihk5CJfktOQbfXCKfoVU5BPGC9jVmFd7-bJuFvIBeJquLqhPFLpkTIWq3jZyXLeWopqOjc6GzKzIOV5BmLiXkypJ79aRm4614jFaMg-0IJ46NN_R_D60TnfsqffD8bF8dHptzfsGf123wGHtthgdn0D22gTzfxOXPj3LHkE_w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detecting+disability+using+self-reported+and+clinical+assessments+in+early-stage+relapsing-remitting+multiple+sclerosis%3A+Looking+for+a+complementary+approach&rft.jtitle=Multiple+sclerosis+journal+-+experimental%2C+translational+and+clinical&rft.au=Sainz+de+la+Maza%2C+Susana&rft.au=G%C3%B3mez-Ballesteros%2C+Roc%C3%ADo&rft.au=Borges%2C+M%C3%B3nica&rft.au=Mart%C3%ADn-Mart%C3%ADnez%2C+Jes%C3%BAs&rft.date=2023-04-01&rft.issn=2055-2173&rft.eissn=2055-2173&rft.volume=9&rft.issue=2&rft_id=info:doi/10.1177%2F20552173231169475&rft.externalDBID=n%2Fa&rft.externalDocID=10_1177_20552173231169475
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-2173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-2173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-2173&client=summon